Total Funding
35
2
Total FundingPrivate Equity raised
Growth Score
-2 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1268832
Inflamalps is a biopharmaceutical company established in Valais, Switzerland.
- Eduard Vidovic: Chief Medical Officer
Andrea Cesura: Chief Scientific Officer
About the Company
Inflamalps is a biopharmaceutical company established in Valais, Switzerland.
Their mission is ‘’to discover and develop novel medicines to treat inflammation with a focus on chronic inflammatory diseases of the eye and of the skin” Their team comprises experienced pharmaceutical industry and biotechnology company managers with significant track
record in drug development, management and financing.
Their focus is on developing topical treatments for inflammation-mediated diseases in ophthalmology and dermatology.
